Analysts Weigh In On Keryx Biopharmaceuticals Following 2Q:15 Results
Keryx Biopharmaceuticals (NASDAQ:KERX) reported second-quarter financial results yesterday and provided an update on its ongoing US launch of its dialysis drug, Auryxia. The Boston-based …
Apple Inc. (AAPL) Tumbles to Lowest Point Since January: Analysts Weigh In
On Wednesday, August 5, shares of Apple Inc. (NASDAQ:AAPL) tumbled down to its lowest point since January as investor sentiment on the stock …
Fitbit Inc. (FIT) to Announce First Earnings as Public Company: Analyst Bullish
Fitbit Inc. (NYSE:FIT), a wearable technology company, is set to announce its Q2 fiscal 2015 earnings on August 5 after market close.
Canaccord Weighs In On InvenSense Inc (INVN) Following Earnings Report
InvenSense Inc (NYSE:INVN) published its fiscal first-quarter earnings after market close on August 4. Canaccord analyst Matthew Ramsay weighed in with bullish sentiments, …
Analysts Weigh In on Regeneron Pharmaceuticals Inc (REGN) Following Earnings Report
On Tuesday, August 4, before market open, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported its second-quarter 2015 financial results that beat both top and bottom line expectations. The biotech giant, which recently …
Roth Capital Weighs in on Biotech: Sarepta Therapeutics Inc (SRPT), Bluebird Bio Inc (BLUE), Agios Pharmaceuticals Inc (AGIO)
On August 2, Roth Capital analyst Debjit Chattopadhyay published a report providing a list of upcoming catalysts for several biotechnology companies including Sarepta Therapeutics Inc (NASDAQ:SRPT), Bluebird Bio Inc (NASDAQ:BLUE), and Agios …
Roth Capital Weighs in on Biotech: Sarepta Therapeutics Inc (SRPT), Bluebird Bio Inc (BLUE), Agios Pharmaceuticals Inc (AGIO)
On August 2, Roth Capital analyst Debjit Chattopadhyay published a report providing a list of upcoming catalysts for several biotechnology companies including Sarepta Therapeutics Inc (NASDAQ:SRPT),Bluebird Bio Inc (NASDAQ:BLUE), and Agios Pharmaceuticals …
The Top 6 Best Analyst Coverage on Intercept Pharmaceuticals Inc (ICPT)
Intercept Pharmaceutical Inc (NASDAQ:ICPT), a clinical stage bio-pharmaceutical company focused on the development and commercialization of novel therapeutics to treat underserved liver diseases, …
Micron Technology, Inc. (MU) And Intel Corporation (INTC) Unveil New Class Of Memory Chips; Analyst Weighs In
On July 28, Micron Technology, Inc. (NASDAQ:MU) and Intel Corporation (NASDAQ:INTC) unveiled production plans for a new, non-volatile memory chip that will revolutionize the way …
The Top 3 Best Analyst Coverage on Yelp Inc (YELP)
Yelp Inc (NYSE:YELP) is scheduled to announce second-quarter 2015 earnings after market close on Tuesday, July 28. The Street anticipates the company to post $0.